The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback